Elucidating the role of gut microbiota metabolites in diabetes by employing network pharmacology
2024 · Molecular Medicine · 25 citations
https://doi.org/10.1186/s10020-024-01033-0
P
Pengyu Tao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
228
Citations
8
h-index
8
i10-index
Pengyu Tao is an academic researcher from Capital Medical University. The author has contributed to research in topics: Gut microbiota and health & Diet and metabolism studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 8, co-authored 18 publications.
ORCID: 0000-0001-5024-8686Papers by this author
worksKangxianling formula attenuates renal fibrosis by regulating gut microbiota
2024 · European journal of medical research · 8 citations
https://doi.org/10.1186/s40001-024-01778-8
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
2024 · Renal Failure · 8 citations
https://doi.org/10.1080/0886022x.2024.2354444
Exploring the beneficial effect of gut microbiota metabolites on diabetic nephropathy via network pharmacology study
2025 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-025-95824-y
The application of metabolites derived from gut microbiota to the treatment of chronic kidney disease: a network pharmacology study
2025 · International Journal of Surgery · 1 citations
https://doi.org/10.1097/js9.0000000000003895
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat